Similar articles for PMID: 29343907

Year	Number of Results
2007	1
2009	5
2010	3
2011	3
2012	4
2013	7
2014	8
2015	8
2016	7
2017	11
2018	6
2019	8
2020	14
2021	13
2022	1
2023	1
2024	0

1

New therapies in nonmuscle invasive bladder cancer treatment.

Rayn KN, Hale GR, Grave GP, Agarwal PK. Rayn KN, et al. Indian J Urol. 2018 Jan-Mar;34(1):11-19. doi: 10.4103/iju.IJU_296_17. Indian J Urol. 2018. PMID: 29343907 Free PMC article. Review.

2

Current clinical trials in non-muscle invasive bladder cancer.

Siddiqui MR, Grant C, Sanford T, Agarwal PK. Siddiqui MR, et al. Urol Oncol. 2017 Aug;35(8):516-527. doi: 10.1016/j.urolonc.2017.06.043. Urol Oncol. 2017. PMID: 28778250 Free PMC article. Review.

3

Psychometric Evaluation of a Patient-Reported Symptom Index for Nonmuscle Invasive Bladder Cancer: Field Testing Protocol.

Rutherford C, King MT, Smith DP, Costa DS, Tait MA, Patel MI; NMIBC-SI Working Group. Rutherford C, et al. JMIR Res Protoc. 2017 Nov 8;6(11):e216. doi: 10.2196/resprot.8761. JMIR Res Protoc. 2017. PMID: 29117930 Free PMC article.

4

Emerging intravesical therapies for management of nonmuscle invasive bladder cancer.

Tomaszewski JJ, Smaldone MC. Tomaszewski JJ, et al. Open Access J Urol. 2010 May 19;2:67-84. Open Access J Urol. 2010. PMID: 24198616 Free PMC article. Review.

5

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.

Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, Zehir A, Schultz N, Rosenberg JE, Bajorin DF, Dalbagni G, Al-Ahmadie H, Solit DB, Bochner BH. Pietzak EJ, et al. Eur Urol. 2017 Dec;72(6):952-959. doi: 10.1016/j.eururo.2017.05.032. Epub 2017 Jun 3. Eur Urol. 2017. PMID: 28583311 Free PMC article.

6

Current advances in BCG-unresponsive non-muscle invasive bladder cancer.

Tse J, Singla N, Ghandour R, Lotan Y, Margulis V. Tse J, et al. Expert Opin Investig Drugs. 2019 Sep;28(9):757-770. doi: 10.1080/13543784.2019.1655730. Epub 2019 Aug 15. Expert Opin Investig Drugs. 2019. PMID: 31412742 Review.

7

Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments.

Gupta M, Kates M, Bivalacqua TJ. Gupta M, et al. Curr Opin Oncol. 2019 May;31(3):183-187. doi: 10.1097/CCO.0000000000000533. Curr Opin Oncol. 2019. PMID: 30893148 Review.

8

Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer.

Meng MV, Gschwend JE, Shore N, Grossfeld GD, Mostafid H, Black PC. Meng MV, et al. J Urol. 2019 Dec;202(6):1111-1119. doi: 10.1097/JU.0000000000000297. Epub 2019 May 1. J Urol. 2019. PMID: 31042108 Review.

9

Best practice in the treatment of nonmuscle invasive bladder cancer.

Anastasiadis A, de Reijke TM. Anastasiadis A, et al. Ther Adv Urol. 2012 Feb;4(1):13-32. doi: 10.1177/1756287211431976. Ther Adv Urol. 2012. PMID: 22295042 Free PMC article.

10

Diagnostics techniques in nonmuscle invasive bladder cancer.

Soubra A, Risk MC. Soubra A, et al. Indian J Urol. 2015 Oct-Dec;31(4):283-8. doi: 10.4103/0970-1591.166449. Indian J Urol. 2015. PMID: 26604438 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year